Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

HgCapital reports resilient first half

(Sharecast News) - HgCapital Trust reported a resilient first-half trading performance on Monday, despite headwinds from market volatility and currency movements, with strong growth across its portfolio companies and continued deal activity. In a preliminary update for the six months ended 30 June, the private equity investment trust reported an estimated net asset value (NAV) per share of 540.2p, equivalent to total net assets of £2.5bn.

Net asset value total return was marginally negative at -0.3%, as a 1.7% gain in the second quarter offset a 2.0% decline in the first.

HgCapital Trust's underlying portfolio companies delivered strong operational performance, with trailing 12-month revenue and EBITDA growth of 19% to the end of May.

That contributed a 7% uplift in portfolio value.

However, the impact of falling valuation multiples amid wider public market volatility detracted 4% from net asset value, while adverse currency movements and increased net debt reduced it by a further 2%.

Investment activity remained robust, with £306m deployed during the period, including new and follow-on investments in IFS, P&I, Citation and Scopevisio.

Co-investments, which are exempt from management fees and carried interest, accounted for £34m and now represented 10% of net asset value.

Realisations generated £165m, including exits from P&I, Citation, Trackunit and smartTrade.

A further £49m had been committed since the period ended, including a new investment in compliance specialist A-LIGN, expected to close in August.

HgCapital Trust also made a $1bn commitment to Hg's Saturn 4 fund during the first half.

On a pro-forma basis, including recent foreign exchange movements and additional fund commitments, the trust's available liquid resources stood at £383m, while outstanding commitments to Hg funds totalled £1.7bn, expected to be drawn over the next four to five years.

The trust highlighted encouraging prospects for the second half of the year, citing improved deal activity across Hg's portfolio.

In total, Hg said it had deployed $4.5bn across its funds year-to-date, while realisations exceeded $2bn.

The manager noted that compared favourably to industry peers amid what it described as a "challenging" liquidity environment.

HgCapital Trust said it would publish its full interim results on 15 September.

At 1004 BST, shares in HgCapital Trust were up 0.2% at 512p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.